Plasmacytoid predendritic cells initiate psoriasis through interferon-α production

Frank O. Nestlé(University Hospital of Zurich), Curdin Conrad(University Hospital of Zurich), Adrian Tun-Kyi(University Hospital of Zurich), Bernhard Homey(Heinrich Heine University Düsseldorf), Michael Gombert(Heinrich Heine University Düsseldorf), Onur Boyman(University Hospital of Zurich), Günter Burg(University Hospital of Zurich), Yong-Jun Liu(The University of Texas MD Anderson Cancer Center), Michel Gilliet(University Hospital of Zurich)
The Journal of Experimental Medicine
July 4, 2005
Cited by 1,098Open Access
Full Text

Abstract

Psoriasis is one of the most common T cell-mediated autoimmune diseases in humans. Although a role for the innate immune system in driving the autoimmune T cell cascade has been proposed, its nature remains elusive. We show that plasmacytoid predendritic cells (PDCs), the natural interferon (IFN)-alpha-producing cells, infiltrate the skin of psoriatic patients and become activated to produce IFN-alpha early during disease formation. In a xenograft model of human psoriasis, we demonstrate that blocking IFN-alpha signaling or inhibiting the ability of PDCs to produce IFN-alpha prevented the T cell-dependent development of psoriasis. Furthermore, IFN-alpha reconstitution experiments demonstrated that PDC-derived IFN-alpha is essential to drive the development of psoriasis in vivo. These findings uncover a novel innate immune pathway for triggering a common human autoimmune disease and suggest that PDCs and PDC-derived IFN-alpha represent potential early targets for the treatment of psoriasis.


Related Papers

No related papers found

Powered by citation graph analysis